Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schellong

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Klinische Padiatrie|July 1, 1992
[Ifosfamide and the metabolites of side chain oxidation--excretion in urine in various pediatric therapeutic protocols]J Boos, U Welslau, J Ritter, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|February 1, 1977
[The development of children following intra-uterine transfusions in severe Rh-erythroblastosis (author's transl)]G Schellong, D Palm, E M Maier-Becker, et al.
Cancer|December 15, 1987
Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemiaU Creutzig, J Ritter, M Budde, et al.
Klinische Padiatrie|July 1, 1991
[Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study]J U Hassel, J H Brämswig, W Schlegel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in childrenJ Boos, U Welslau, J Ritter, et al.
Bulletin Du Cancer|January 1, 1988
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studiesG Schellong, J H Brämswig, E W Schwarze, et al.
Lancet (London, England)|March 6, 1982
Cranial computerised tomography in isosexual precocious pubertyJ H Brämswig, G Schellong, R P Müller, et al.
Haematology and Blood Transfusion|January 1, 1987
The childhood AML studies BFM-78 and -83: treatment results and risk factor analysisU Creutzig, J Ritter, H Riehm, et al.
Deutsche Medizinische Wochenschrift (1946)|December 4, 1981
[Testosteron treatment of excessively tall boys (author's transl)]J H Brämswig, G Schellong, H J Borger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of GermanyJ Ritter, U Creutzig, A Reiter, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Klinische Padiatrie|July 1, 1992
[Ifosfamide and the metabolites of side chain oxidation--excretion in urine in various pediatric therapeutic protocols]J Boos, U Welslau, J Ritter, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|February 1, 1977
[The development of children following intra-uterine transfusions in severe Rh-erythroblastosis (author's transl)]G Schellong, D Palm, E M Maier-Becker, et al.
Cancer|December 15, 1987
Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemiaU Creutzig, J Ritter, M Budde, et al.
Klinische Padiatrie|July 1, 1991
[Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study]J U Hassel, J H Brämswig, W Schlegel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in childrenJ Boos, U Welslau, J Ritter, et al.
Bulletin Du Cancer|January 1, 1988
An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studiesG Schellong, J H Brämswig, E W Schwarze, et al.
Lancet (London, England)|March 6, 1982
Cranial computerised tomography in isosexual precocious pubertyJ H Brämswig, G Schellong, R P Müller, et al.
Haematology and Blood Transfusion|January 1, 1987
The childhood AML studies BFM-78 and -83: treatment results and risk factor analysisU Creutzig, J Ritter, H Riehm, et al.
Deutsche Medizinische Wochenschrift (1946)|December 4, 1981
[Testosteron treatment of excessively tall boys (author's transl)]J H Brämswig, G Schellong, H J Borger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of GermanyJ Ritter, U Creutzig, A Reiter, et al.
Pageof 14